IDEAYA Biosciences (NASDAQ: IDYA) reported Q1 EPS of ($0.49), $0.05 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $7.88 million versus the consensus estimate of $7.17 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.